Oxford-developed Ebola vaccine enters Phase I clinical trial in Uganda
An Oxford-developed vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus caused by Bundibugyo virus (BDBV), entered a Phase I clinical study in Uganda on 6t...